Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria
about
The pp24 phosphoprotein of Mason-Pfizer monkey virus contributes to viral genome packagingCharacterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayIn vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.Type D retrovirus capsid assembly and release are active events requiring ATP.Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopyType D retrovirus Gag polyprotein interacts with the cytosolic chaperonin TRiC.Characterization of Rous sarcoma virus Gag particles assembled in vitro.Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape.A LINE-like transposable element in Drosophila, the I factor, encodes a protein with properties similar to those of retroviral nucleocapsids.The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assemblyModulation of HIV-like particle assembly in vitro by inositol phosphates.Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag.Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins.Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli.Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein.Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switchSynthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopyThe impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virusRous sarcoma virus Gag protein-oligonucleotide interaction suggests a critical role for protein dimer formation in assembly.Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro.Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging.Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.Higher-order structure of the Rous sarcoma virus SP assembly domain.N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.Separate assembly and transport domains within the Gag precursor of Mason-Pfizer monkey virusConserved and variable features of Gag structure and arrangement in immature retrovirus particles.Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates.In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.Plasma membrane targeting of chimeric intracisternal A-type particle polyproteins leads to particle release and specific activation of the viral proteinase.In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV.Expression, purification, and characterization of biologically active full-length Mason-Pfizer monkey virus (MPMV) Pr78
P2860
Q24815700-F0A3B8B7-1F86-4FC7-9D35-EB819BCFBA30Q28477791-37E553C2-7005-4BED-A90B-E931360727CAQ33653475-5D214CA7-89B4-4DAC-8E16-A29DD5229BA5Q33782770-6993284B-6B1A-4C3A-94D9-AE7CD843B71BQ33783128-94636CC7-6E21-46D1-8760-DF9935E3F12EQ33815050-FFBD2251-A63B-422B-A3B2-1804B84F41DDQ33820522-85424342-5AB9-4254-8AC3-E45378AED731Q33846187-EBC063E2-E004-4141-A163-3AAFD78698D8Q33865019-04DE69A7-0753-4EB0-8F8E-87406A7A527CQ33865636-A0A80B1A-F1E8-4B65-A9B5-8711838F6F57Q33874074-68F3A6A0-D854-46C6-9614-CF3CA8277740Q33887141-0E9B27E7-B2EB-4BCD-9E6B-E5EB0514D63EQ33887537-6531069A-1D49-4EAB-AE79-108902FC65E4Q33943917-C59F279E-340E-46FC-B11F-1E9FD45C474EQ34304675-0A087E7C-70C3-49CE-8400-3026193671D4Q34350076-5E1402A5-4D96-4AA9-A74C-8D6C3836151AQ34717899-87A962D9-DE6B-476C-A70C-3C9CF73178B3Q34999719-B9CCB109-5B6A-4D70-9E10-64893A61E97FQ35477673-7E29E5EC-CE6A-4B78-92E3-465EA71B4D1FQ35691189-A0DE97C3-311B-482B-BB1C-C5451538A5F4Q35861388-4E96F8CA-E4B1-4261-94CA-3D2F5BEC9226Q36098951-EAEC6C21-D4AC-4841-AC02-E356860FE90EQ36325523-E7FD7888-EC75-41E5-B644-78EDBBA89B5DQ37189392-CC1BD63F-E2E7-417B-AB8A-7C4789772217Q38289565-BF9070EA-2099-4446-BF07-A9F06ED5FEF2Q38346922-FBC4CFFE-FC9A-45FD-823B-8015041F3CDBQ38791252-5585DB72-C19B-4A67-B17C-B3691AAF3EC0Q39539672-9802F527-7A35-45EF-9887-AC8C45BBCDADQ39549065-0B6FC6D7-F0A5-47CE-A3B9-4CC2FF9EB5D2Q39580545-42A272FC-B8DE-4138-A29E-79926C41FD76Q39595748-808E05D9-5289-40EC-AD73-70D9E0D052E3Q39660817-CD092793-158E-4352-9551-23E971EC435BQ39877044-B67AF37F-70DA-44A4-A8B1-B11EC2768086Q39879873-697232F3-BACA-4540-AC53-E2D28E7E8F47Q39880210-1261872F-53D1-4908-B669-33CDEAA9740AQ40605953-447A41FB-E5D2-4BE9-812E-522BBB5AFF1AQ58797758-294E0E8A-D937-40D2-9A0E-7FF3FE82C666
P2860
Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Efficient in vivo and in vitro ...... proteins expressed in bacteria
@en
Efficient in vivo and in vitro ...... roteins expressed in bacteria.
@nl
type
label
Efficient in vivo and in vitro ...... proteins expressed in bacteria
@en
Efficient in vivo and in vitro ...... roteins expressed in bacteria.
@nl
prefLabel
Efficient in vivo and in vitro ...... proteins expressed in bacteria
@en
Efficient in vivo and in vitro ...... roteins expressed in bacteria.
@nl
P2093
P2860
P1433
P1476
Efficient in vivo and in vitro ...... proteins expressed in bacteria
@en
P2093
P2860
P304
P407
P577
1995-02-01T00:00:00Z